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Background: To assess which of three methods, namely, optical coherence tomography (OCT), pattern
electroretinogram (PERG) or frequency-doubling technology (FDT), is the most sensitive and specific for detecting
early glaucomatous damage in ocular hypertension (OH).
Methods: Fifty-two patients with OH (24 men and 28 women, mean age of 56 ± 9.6 years) with an intraocular
pressure (IOP) > 21 mmHg and fifty-two control patients (25 men and 27 women, mean age of 54.8 ± 10.4 years)
with IOP < 21 mmHg, were assessed. All the patients had normal visual acuity, normal optic disk and normal
perimetric indices.
All subjects underwent OCT, FDT and PERG. Data were analyzed with unpaired t-tests, Chi-square test and Receiver
Operating Characteristic (ROC) curve analyses.
Results: In patients with OH, OCT showed retinal nerve fiber layer (RNFL) thinner than in control group in the
superior quadrant (130.16 ± 10.02 vs 135.18 ± 9.27 μm, respectively; p < 0.011) and inferior quadrant (120.14 ± 11.0 vs
132.68 ± 8.03 μm; p < 0.001). FDT showed a significantly higher pattern standard deviation (PSD) (3.46 ± 1.48 vs
1.89 ± 0.7 dB; p < 0.001). With respect to PERG, only the amplitude showed significant differences (p < 0.044)
between the two groups. ROC curve analysis revealed a sensitivity and specificity of 92% and 86%, respectively, for
FDT-PSD (with an area under the ROC curve of 0.940), whereas with OCT, a sensitivity of 82% and a specificity of
74% was recorded in the inferior RNFL quadrant (with an area under the ROC curve of 0.806) finally with PERG
amplitude we found a sensitivity of 52% and specificity of 77% (with an area under the ROC curve of 0.595).
Conclusions: FDT is the most sensitive and specific method for detecting early glaucomatous damage in eyes with
OH, and together with OCT, can be useful in identifying those patients who may develop glaucoma.
Trial registration: ISRCT number: ISRCTN70295497
Keywords: Frequency-doubling technology, Ocular hypertension, Optical coherence tomography, Pattern
electroretinogram, Retinal ganglion cells, Retinal nerve fiber layerBackground
Glaucoma is an optic neuropathy characterized by the
progressive loss of ganglion cells and visual field altera-
tions. Systematic review of all population based surveys
on blindness and low vision in 2006 estimated 60.5 mil-
lion people with glaucoma worldwide in 2010, with
bilateral blindness in 8.4 million people [1]. The* Correspondence: mauro.cellini@unibo.it
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reproduction in any medium, provided the orappearance of alterations in the retinal nerve fiber layer
represents an early sign of glaucoma damage that
precedes changes in the optic nerve and peripheral
alterations [2].
The current quantitative techniques used for examin-
ation of the retinal nerve fiber layer (RNFL) are scanning
laser polarimetry (SLP) [3], Heidelberg retinal tomog-
raphy (HRT) [4] and, more recently, optical coherence
tomography (OCT) [5]. OCT makes it possible to exam-
ine high-resolution cross-sections of ocular tissues using
the principle of low coherence interferometry [6,7] andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ation of the RNFL [8].
Due to the irreversible nature of the retinal ganglion
cell loss and axonal damage in glaucoma, it is particu-
larly important to use high-quality investigative techni-
ques to facilitate the early detection of functional
deterioration in susceptible patients [9]. The qualitative
analysis methods currently available are standard achro-
matic perimetry (SAP) and short wavelength automated
perimetry (SWAP) [10,11], as well as the recent
frequency-doubling technology (FDT) perimetry [12].
The pattern electroretinogram (PERG) was introduced
25 years ago as a method to discriminate between
healthy and glaucomatous eyes by recording the elec-
trical potentials of retinal ganglion cells [13-15]. Gan-
glion cell damage is the main cause of decreased visual
sensitivity in glaucomatous eyes [16,17]. In this context,
this study assessed which of the three methods, OCT,
FDT or PERG, is the most sensitive and specificity for
the early detection of glaucomatous damage in a group
of patients with ocular hypertension (OH), the most
widely recognized risk factor for progression of glau-
comatous damage.
Methods
The OCT, FDT and PERG examinations of 52 patients,
consisted of 28 women and 24 men aged between 44
and 76 years (mean 56 ± 9.6 years), were analyzed. All
patients had an intraocular pressure (IOP) greater than
21 mmHg (mean 23.96 ± 1.3 mmHg) and with no other
ocular (e.g., cataracts or other opacities) or systemic dis-
eases. The patients all had normal visual acuity (VA), a
normal optic disk (in particular, with no sign of diffuse
thinning or focal narrowing or notching of the neuroret-
inal rim, hemorrhage, cupping or visible or progressive
changes in the fiber layer on ophthalmoscopic examin-
ation with a +78 diopter lens) and mean defect (MD)
and pattern standard deviation (PSD) perimetric indices
of less than 1.5 dB (0.28 ± 1.1 and 0.65 ± 0.4, respect-
ively). All patients were recruited from the Glaucoma
Service of the S. Orsola-Malpighi Hospital of Bologna.
The control group consisted of 55 subjects: 28 males
and 27 females aged between 42 and 75 years (mean
54.8 ± 10.4 years). The healthy controls had no ongoing
eye or systemic disorders nor such a history, an IOP of
less than 21 mmHg, a normal optic nerve and normal
visual field indices.
A normal visual field was defined by the absence of
each of these responses: a cluster of 3 points lower than
P < 5% or a cluster of 2 points lower than P < 1% on a
pattern deviation plot, or PSD with P < 5%.
Only one eye per subject, both in the OH and the con-
trol groups, was randomly chosen if both eyes were eli-
gible for the study.The study was approved by the Local Ethics Commit-
tee of the S. Orsola-Malpighi Hospital, Bologna. An oral
informed consent was obtained from all the patients.
All patients underwent an ophthalmologic examin-
ation including visual acuity, applanation tonometry IOP
assessment, corneal radius curvature measurement with
automated keratometry (RK, Canon Inc., Tokyo, Japan),
corneal thickness evaluation with a Tomey SP3000
pachymeter (Tomey Corp., Nagoya, Japan), biomicro-
scopy of the anterior and posterior segment with auto-
matic measurement of the cup/disc (C/D) area ratio of
the optic nerve head with an Stratus OCT 3 (Zeiss-
Humphrey, Dublin, CA, USA). SAP was also performed
with a Humphrey Field Analyzer-30.2, using the full-
threshold program (Zeiss-Humphrey, Dublin, CA, USA).
Three visual field tests were performed for each OH
and healthy control individual, and only the results of
the third test were assessed. All subjects underwent as-
sessment of the RFNL with the Stratus OCT 3 (Zeiss-
Humphrey, Dublin, CA), FDT perimetry with the FDT
Visual Field Instrument (Welch-Allin FDT, Skaneatsles
Falls, NY, USA and CarlZeiss, Meditec Inc., Dublin, CA,
USA), and PERG with the RetimaxPlus system (CSO
Instruments, Florence, Italy). For FDT, only the results
of the third test were assessed, and the FDT and SAP
were reviewed separately by two investigators who were
blinded to any clinical data.
OCT scanning
The OCT technique makes it possible to analyze the
retinal structures and obtain in vivo tomographic sec-
tions illustrating the histological retinal structure. This
instrument use low coherence interferometry principles,
which separate the retinal microstructures by measur-
ing the echo delay of the light reflected and retrodif-
fused by these structures. The OCT 3 makes it possible
to obtain scans with an axial resolution of 10 μm and
a transverse resolution of 20 μm. The instrument pro-
jects onto the retina a beam of light generated by a
superluminescent diode, with a infrared wavelength
(820 nm). The system detects, processes and stores the
retinal delay patterns and displays and stores the
selected scans so that they can be subsequently ana-
lyzed. Each eye was dilated with 1% tropicamide before
recording the images, and internal fixation was chosen
because it provides better reproducibility than external
fixation.
This instrument was used to directly measure the
thickness of the peripapillary RNFL using the RNFL
Thickness Averaging program, in which three consecu-
tive, circular scans are performed, each one 3.4 mm in
diameter and centered on the optic nerve. The thickness
of the fibers was defined as the number of pixels
obtained between the anterior and posterior RNFL




Male: Female 27:25 24:28 0.765*
Age (years) 54.8 ± 10.4 56 ± 9.6 0.431
IOP (mmHg) 16.7 ± 1.5 23.96 ± 1.3 0.001
Refractive errors (diopters) - 0.2 ± 1.5 - 0.4 ± 1.6 0.320
Visual acuity (LogMAR) 0.0 ± 0.1 0.0 ± 0.1 1.00
Corneal radius (mm) 7.76 ± 0.14 7.83 ± 0.14 0.210
Corneal thickness (μm) 552.3 ± 3.08 558.4 ± 4.15 0.274
C/D area ratio 0.33 ± 0.11 0.37 ± 0.12 0.068
Visual field MD (dB) 0.28 ± 1.1 0.31 ± 1.2 0.670
Visual field CPSD (dB) 0.65 ± 0.4 0.90 ± 0.5 0.542
Demographics data of intraocular pressure (IOP), cup/disc area ratio (C/D),
visual field mean defect (MD), visual field corrected pattern standard deviation
(CPSD), “*” Chi-square test for ocular hypertensive (OH) patients and controls.
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played in graphical form, resembling a clock face divided
into four quadrants, representing the superior, nasal, in-
ferior and temporal sections of the RNFL expressed in
microns.
FDT perimetry
FDT perimetry is a new technique designed for the rapid
and effective identification of visual field impairment
due to glaucoma. The FDT stimulus consists of a bar
grid with a low-frequency spatial sinusoidal profile (0.25
cycles/degree) subjected to a sinusoidal temporal com-
mutation at a frequency of 25 Hz. FDT is based on the
principle of the frequency-doubling illusion, in which
the subject perceives twice the number of bars actually
presented [18]. The cells that present a nonlinear re-
sponse to the contrast in the test image, which are
therefore responsible for this illusion, are a subgroup of
M cells [19].
FDT was performed using the full-threshold program
N-30. With this test, target stimuli consisted of individ-
ual sinusoidal gratings, 10 degrees square at 0.25
cycles/degree, alternately flashing at 25 MHz. Targets
were in one of the 19 areas within the central 30
degrees of the visual field. For each visual field, we eval-
uated the mean defect (MD) and the pattern standard
deviation (PSD).
PERG recording
For PERG recording, we followed the International Soci-
ety for Clinical Electrophysiology of Vision (ISCEV)
standard guidelines [20].
The patient sat in a chair at a distance of 114 cm from
the television screen. The generated potential was mea-
sured with skin electrodes. The ground electrode was
placed on the right ear lobe, and the interelectrode re-
sistance was less than 3 kW. The PERG stimulus was a
black-and-white checkerboard with a contrast of 99% at
1.6 cycles/degree, four reversal/s and a mean luminance
of 110 cd/m2. The monitor screen subtended a visual
angle of 12.5°. The refraction of all subjects was cor-
rected for the viewing distance. No mydriatic or miotic
drugs were used. The transient PERG response was
characterized by three subsequent peaks that, in normal
subjects, are indicated on the basis of polarity and la-
tency: N35, P50 and N95. The P50 amplitude was mea-
sured from the trough of N35 to the peak of P50. In
some patients, the N35 was poorly defined; in these
cases, N35 was replaced with the average between time
zero and the onset of P50.
Statistical analysis
All statistical analyses were performed using the FAS-
TAT Version 2 software package (Systat Inc., Evanston,Illinois). Unpaired student’s t-test was used taking
p < 0.05 as significant. The Chi-square test was used for
categorical data. The Receiver Operating Characteristic
(ROC) curve analysis was performed to determine the
diagnostic sensitivities and specificities of OCT, FDT,
and PERG. To compare ROC curve areas, Delong test
was used.Results
The demographic and ocular characteristics of the OH
patients and healthy controls are presented in Table 1.
No significant differences in clinical and epidemiologic
factors were found between the two groups, except for
IOP (p < 0.001). The other predictive factors for the de-
velopment of glaucoma (age, cup-disc ratio and central
corneal thickness) were similar in the two groups.
OCT revealed RNFL thinning in all quadrants in the
OH patients compared with the healthy controls, but
this was significant (p < 0.05) only for the superior and
inferior quadrants. FDT showed only a significantly
higher PSD (p < 0.001) in OH patients than in healthy
controls (Table 2). Regarding PERG, we found a
decreased amplitude (p < 0.044) in the OH patients,
whereas for latency, no significant differences were
found between the two groups. ROC curve analysis
revealed a sensitivity and specificity of 92% and 86%, re-
spectively, for FDT-PSD, whereas for OCT, a sensitivity
of 82% and a specificity of only 74% was recorded in the
inferior RNFL quadrant. Finally the PERG amplitude
had a sensitivity 52% of and specificity of 77% (Table 3
and Figure 1). OCT measured inferior quadrant RNFL
thickness and FDT PSD discriminated between OH and
healthy eyes better than PERG amplitude (p = 0.04 and
<0.0001, respectively). Moreover, FDT PSD discrimi-
nated between OH and healthy eyes better than OCT
measured inferior quadrant RNFL thickness (p = 0.01).
Table 2 Mean values for RNFL thickness, FDT perimetric
indices and PERG P50 amplitudes and latency values in
OH patients and controls
Controls Ocular Hypertension p< 0.05
RNFL superior (μm) 135.18 ± 9.27 130.16 ± 10.02 0.011
RNFL inferior (μm) 132.68 ± 8.03 120.14 ± 11.01 0.001
RNFL nasal (μm) 82.97 ± 7.15 81.30 ± 3.74 0.146
RNFL temporal (μm) 85.97 ± 5.92 84.42 ± 3.66 0.118
FDT-MD (dB) −1.78 ± 0.75 −2.09 ± 1.29 0.145
FDT-PSD (dB) 1.89 ± 0.70 3.46 ± 1.48 0.001
PERG amplitude (μVolt) 1.70 ± 0.70 1.52 ± 0.25 0.044
PERG latency (ms) 55.13 ± 2.24 55.85 ± 4.12 0.139
Mean values for retinal nerve fiber layer (RNFL) thickness obtained with optical
coherence tomography (OCT), frequency doubling technology (FDT) mean
defect (MD) and pattern standard deviation (PSD) perimetric indices and
pattern electroretinogram (PERG) of the wave P50 amplitudes and latency
values in OH patients and controls.
Figure 1 The ROC curves of the indices, doubling frequency
technology (FDT) pattern standard deviation (PSD), pattern
electroretinogram (PERG) amplitude and optical coherence
tomography (OCT) evaluation of the inferior retinal nerve fiber
layer (RNFL), with the highest sensitivity/specificity ratio.
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Glaucoma is the second cause of blindness worldwide
[1] and an early diagnosis is important to treat it
promptly in order to avoid or reduce the progression of
visual field defects. At least 25 to 30% of RGC is already
lost when visual field defects are detectable by SAP [21].
Elevated IOP is the most important risk factor for glau-
coma onset and progression [22], but the treatment of
only high-risk patients with OH should be considered
[23]. So, it is important to identify those patients with
elevated IOP who have early stage glaucoma in order to
decide when patient need a therapy.
In our study OCT of the retinal nerve fiber layer
revealed a significant reduction in thickness in the infer-
ior quadrant of the optic disc in OH compared with
healthy controls, with a sensitivity of 82% and a specifi-
city of 74%. Several studies suggested that optic nerve
and RFNL impairment can generally be identified before
SAP alterations [24-26]. We could speculate that at theTable 3 The area under ROC curve
Sensitivity Specificity AUC (95% CI)
RNFL superior 56% 76% 0.510 (0.391 to 0.630)
RNFL inferior 82% 74% 0.806 (0.717 to 0.898)
RNFL temporal 58% 70% 0.633 (0.518 to 0.748)
RNFL nasal 60% 52% 0.575 (0.458 to 0.691)
MD-FDT 48% 74% 0.528 (0.412 to 0.644)
PSD-FDT 92% 86% 0.940 (0.876 to 0.979)
PERG amplitude 52% 77% 0.654 (0.552 to 0.746)
PERG latency 42% 72% 0.593 (0.480 to 0.707)
Percentage sensitivities and specificities of retinal nerve fiber layer (RNFL)
thickness, frequency doubling technology (FDT) mean defect (MD) and pattern
standard deviation (PSD) and pattern electroretinogram (PERG) amplitude and
latency area under Receiver Operating Characteristic (ROC) curve. AUC= area
under the curve; CI = confidence interval.onset of glaucoma, only the peripheral visual field is
impaired, and thus, the initial sight deficit is not
detected by the automated techniques currently in use
[27]. OCT morphology correspond well to histopatho-
logical findings [28]. The RNFL thinning observed in
our OH patients confirms previous studies, where differ-
ent methods of analysis were used, like OCT [29], scan-
ning laser polarimetry [30] or confocal scanning laser
ophthalmoscope [31,32].
Furthermore FDT shows a significant increase in the
PSD index in hypertensive eyes, with a sensitivity of 92%
and a specificity of 86%. FDT is a highly sophisticated
method, that examine the functionality of a subgroup of
magnocellular ganglion cells [12], called My cells, that
represent just 3% of all retinal ganglion cells [33,34].
Histopathological experimental studies of optic nerve in
glaucoma patients suggest an early and selective impair-
ment of M-cells [35,36]. The percentage of our OH eyes
with abnormal FDT results is comparable with other
studies [26,37-40], but this elevated percentage could be
partially due to false positive results.
Finally with transient PERG, a reduction in P50 ampli-
tude was found in 78% of OH patients, with a sensitivity
of 52% and a specificity of 77%, whereas an increase in la-
tency was found in only 62% of cases. These data are
similar to findings of previous studies, were steady-state
PERG was employed [27,41,42]. PERG measures RGC
functional activity and is correlated with the number of
functioning cells [43,44]. PERG alteration in OH subjects
would confirm that in OH the damage is localized to the
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death [44]. PERG amplitude is inversely related to IOP in
OH group [47]. So, we could suppose that PERG ampli-
tude difference between OH and control group could be
in part due to different IOP values and not to early dis-
ease. Furthermore, the low sensitivity of PERG, which
does not exceed 0.52, in detecting functional damage to
RGC in OH when compared with OCT and FDT, may be
related to the fact that the test stimulus is central in
PERG, whereas glaucomatous impairment initially affects
the peripheral visual field [27]. Instead, FDT might be
more sensitive to peripheral defects because of the distri-
bution of magnocellular cells. Furthermore, PERG
reflects diffuse, non-focal damage to ganglion cells [48],
so the initial focal damage could not be detected and
ocular opacities may also decrease PERG amplitude [49].
This study has several limitations: first, it is retrospect-
ive and this could influence the results. Second, this is a
glaucoma detection study, but the lack of a gold stand-
ard for glaucoma detection makes it difficult to compare
different tests. Third, we evaluated 52 OH patients and
55 controls, but a larger sample size could improve the
diagnostic accuracy of the study.Conclusions
Our study demonstrates that FDT is slightly more sensi-
tive and more specific than OCT in highlighting nerve
fiber alterations in OH. The relatively low sensitivity of
OCT may reflect the fact that this technique, which uses
coherent light, can be influenced by the opacity of the
cornea, lens and the vitreous humor. PERG is also a use-
ful diagnostic technique, although it entails the limita-
tions inherent to any experimental method, as the
procedures used vary considerably between one labora-
tory and another, making it more difficult to standardize
and reproduce than OCT and FDT.
Thus, from a clinical point of view, we think that the
current examination of RNFL thickness using OCT and
the study of RGC functionality with FDT could be very
useful for identifying patients at risk for developing glau-
comatous optic neuropathy.
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